146 related articles for article (PubMed ID: 37735663)
1. Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma.
Imam MS; Abdelazim AH; Ramzy S; Almrasy AA; Gamal M; Batubara AS
BMC Chem; 2023 Sep; 17(1):120. PubMed ID: 37735663
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma.
Imam MS; Abdelazim AH; Batubara AS; Gamal M; Almrasy AA; Ramzy S; Khojah H; Hasanin THA
Sci Rep; 2023 Apr; 13(1):6165. PubMed ID: 37061601
[TBL] [Abstract][Full Text] [Related]
3. Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations.
Imam MS; Batubara AS; Gamal M; Abdelazim AH; Almrasy AA; Ramzy S
Sci Rep; 2023 Jan; 13(1):137. PubMed ID: 36599900
[TBL] [Abstract][Full Text] [Related]
4. Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma.
Batubara AS; Abdelazim AH; Gamal M; Almrasy AA; Ramzy S
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Apr; 290():122265. PubMed ID: 36608515
[TBL] [Abstract][Full Text] [Related]
5. Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.
Batubara AS; Ainousah BE; Ramzy S; Abdelazim AH; Gamal M; Tony RM
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Oct; 299():122880. PubMed ID: 37216820
[TBL] [Abstract][Full Text] [Related]
6. Guava-fruit based synthesis of carbon quantum dots for spectrofluorometric quantitative analysis of risperidone in spiked human plasma and pharmaceutical dosage forms.
Alaqel SI; Abdullah O; Alharbi A; Althobaiti YS; Alturki MS; Ramzy S; Almalki AH
RSC Adv; 2023 Jun; 13(26):17765-17774. PubMed ID: 37323441
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of nirmatrelvir and ritonavir in human plasma using LC-MS/MS and its pharmacokinetic application in healthy Chinese volunteers.
Liu C; Zhu M; Cao L; Boucetta H; Song M; Hang T; Lu Y
Biomed Chromatogr; 2022 Nov; 36(11):e5456. PubMed ID: 35881032
[TBL] [Abstract][Full Text] [Related]
8. Validated spectrofluorimetric method for determination of two phosphodiesterase inhibitors tadalafil and vardenafil in pharmaceutical preparations and spiked human plasma.
Abu El-Enin MA; Al-Ghaffar Hammouda Mel-S; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM
Luminescence; 2016 Feb; 31(1):173-8. PubMed ID: 26019060
[TBL] [Abstract][Full Text] [Related]
9. Homogeneous liquid-liquid microextraction coupled with HPLC/DAD for determination of nirmatrelvir and ritonavir as COVID-19 combination therapy in human plasma.
Abdallah IA; Hammad SF; Bedair A; Mansour FR
BMC Chem; 2023 Nov; 17(1):166. PubMed ID: 38001530
[TBL] [Abstract][Full Text] [Related]
10. Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma.
Ramzy S; Abdelazim AH; Hasan MA
BMC Chem; 2022 Aug; 16(1):62. PubMed ID: 35986381
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of nirmatrelvir/ritonavir in human serum by LC-HRMS.
Zhao F; Xiang Z; Han J; Pan J; Qu Y; Fan K; Wu Z; Xu D; Yu Y; Shen Z; Su C
J Pharm Biomed Anal; 2024 Jan; 237():115796. PubMed ID: 37839266
[TBL] [Abstract][Full Text] [Related]
12. Spectrofluorometric determination of methocarbamol in pharmaceutical preparations and human plasma.
Walash M; Belal F; Eid M; EL Abass SA
J Fluoresc; 2011 Mar; 21(2):555-61. PubMed ID: 20936330
[TBL] [Abstract][Full Text] [Related]
13. A green micelle-enhanced first derivative synchronous fluorescence approach for determination of donepezil HCl and trazodone HCl in their pure state, pharmaceutical dosage form and spiked human plasma.
Abd El Wahab MM; Saad S; Sheribah ZA; El-Enany N
Luminescence; 2024 Jun; 39(6):e4797. PubMed ID: 38837846
[TBL] [Abstract][Full Text] [Related]
14. Green spectrofluorimetric determination of salmeterol xinafoate in its pure forms, medicinal commercial formula, and human plasma: Application for stability studies.
Omar MA; Nagy DM; Ahmed HS; Attia TZ
Luminescence; 2021 Jun; 36(4):937-942. PubMed ID: 33543552
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19.
Martens-Lobenhoffer J; Böger CR; Kielstein J; Bode-Böger SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1212():123510. PubMed ID: 36274268
[TBL] [Abstract][Full Text] [Related]
16. A new fluorescence probe for sofosbuvir analysis in dosage form and spiked human plasma.
Nasr MS; Talaat W; Morshedy S; Kaddah MMY; Omran G; Keshk RM
Luminescence; 2024 Apr; 39(4):e4742. PubMed ID: 38637644
[TBL] [Abstract][Full Text] [Related]
17. White analytical insight for sensitive fluorescent determination of semaglutide and tirzepatide in pharmaceuticals and biological matrices.
Mansour NM; El-Masry AA; El-Sherbiny DT; Moustafa MA
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 313():124159. PubMed ID: 38508074
[TBL] [Abstract][Full Text] [Related]
18. Spectrofluorometric determination of futibatinib in human plasma and pharmaceutical formulations.
Alzhrani RM; Almalki AH; Alosaimi ME; Algarni MA; Abduljabbar MH; Aldawsari MF; Alturki MS; Alsulami FT; Abdelazim AH
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Nov; 320():124543. PubMed ID: 38850821
[TBL] [Abstract][Full Text] [Related]
19. Application of different spectrofluorimetric approaches for quantitative determination of acetylsalicylic acid and omeprazole in recently approved pharmaceutical preparation and human plasma.
El-Olemy A; Abdelazim AH; Ramzy S; Hasan MA; Madkour AW; Almrasy AA; Shahin M
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 262():120116. PubMed ID: 34217146
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19.
Lemaitre F; Budde K; Van Gelder T; Bergan S; Lawson R; Noceti O; Venkataramanan R; Elens L; Moes DJAR; Hesselink DA; Pawinski T; Johnson-Davis KL; De Winter BCM; Pattanaik S; Brunet M; Masuda S; Langman LJ
Ther Drug Monit; 2023 Apr; 45(2):191-199. PubMed ID: 35944126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
